Connect with our scientific experts for your drug discovery, development, and manufacturing needs
We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.
Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.
Personalized medicine is transforming the healthcare landscape by customizing treatment plans to individual patients’ unique genetic, clinical and environmental characteristics. These are effective and less invasive treatments for a wide range of conditions. Contract Research, Development and Manufacturing Organizations (CRDMOs) play an important role in enabling tailored therapies. This whitepaper explores the recent advancements in personalized medicine and how CRDMOs are contributing to accelerate access for patients. Personalized medicine, also known as precision medicine, has emerged as a promising paradigm shift in healthcare. Instead of the traditional one-size-fits-all approach, personalized medicine tailors’ treatments to the unique characteristics of individual patients. These characteristics include genetic variations, biomarkers, clinical history, and environmental factors.
Share your details to download our whitepaper
Why Aurigene Pharmaceutical Services?
18 years of expertise
Experience gained from 100+ discovery programmes
World-class infrastructure
Track record of delivering 8+ IND candidates
Flexible working models
Quick turnaround time
Capabilities to apply multiple modalities
Seamless integration capabilities with Biology as well as CDMO services
Integrated project management
Expertise in various therapeutic modalities
Connect with our scientific experts for your drug discovery, development, and manufacturing needs
We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.
Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.
Learning Resources
Transforming Drug Discovery with Aurigene.AI
In the early 2000s, developing Sovaldi, a hepatitis C treatment, took over a decade and nearly $2 billion. Similarly, Zolgensma, a gene therapy for spinal muscular atrophy, required 15 years due to its complexity. However, the advent of artificial intelligence (AI) has revolutionized drug discovery. For example, in 2022, Pfizer's PAXLOVID, an oral COVID-19 treatm...
Read More
Advancement in personalized medicine and how the CRDMO industry is part of the solution
Personalized medicine is transforming the healthcare landscape by customizing treatment plans to individual patients’ unique genetic, clinical and environmental characteristics. These are effective and less invasive treatments for a wide range of conditions. Contract Research, Development and Manufacturing Organizations (CRDMOs) play an important role in enabli...
Read More
Overcoming challenges with cyclic peptides for In-vitro experiments and Bioanalysis
Project Requirement:Cyclic peptides were to be analyzed for Kinetic solubility, Chrom Log D, MDCK, PAMPA, & Caco2 experiments, while overcoming the challenges associated with the impact of cyclization of peptides on in vitro experiments and bioanalysisWhat were the challenges!1. Nonspecific Binding (NSB)2. Precipitation of peptides while spiking DMSO stock to...
Read More
Development and assessment of a Bcs class II - SGLT2 (Sodium Glucose Cotransporter 2) inhibitor drug in the form of solid lipid Nanoparticles by selecting different lipids, co-surfactants, and manufacturing techniques
2025
Drug Delivery System (DDS) has been used successfully in the past few decades to cure illnesses and enhance health because of its improved systemic circulation and ability to regulate the drug's pharmacological action. As pharmacology and pharmacokinetics advanced, the idea of controlled release emerged, demonstrating the significance of drug release in assessing...
Read More-
Development of novel paullone-based PROTACs as anticancer agents
2025
Proteolysis-targeting chimera (PROTACs) represents a promising modality that has gained significant attention for cancer treatment. Using PROTAC technology, we synthesized novel structurally modified paullone-based PROTACs using Cereblon (CRBN) and Von Hippel–Lindau (VHL) E3 ligands....
Read More -
Development and verification of RP-HPLC method for the quantitative determination of Decitabine in tablet dosage formulation
2025
Decitabine is an anti-cancer chemotherapy drug. This article describes method development and method verification of Assay of Decitabine in tablet formulation. A new, precise, rapid, accurate RP-HPLC method has been developed for the estimation of Decitabine in pharmaceutical tablets dosage form. After optimization the good chromatographic separation was achieved...
Read More -
The Impact of Nano-Suspensions on Drug Delivery: Enhancing Solubility and Therapeutic Efficacy
2025
At large, poor aqueous solubility remains a significant challenge in drug development and formulation limiting bioavailability and therapeutic efficacy. The formulation is deemed successful when it achieves the desired solubility and better bioavailability of the drug, which is important for pharmacological responses. However, 40 percent of newfound chemical enti...
Read More
Sustainable Pharma Is the New Competitive Baseline
2026
A January 2026 panel interview emphasizes that dismissing sustainability undermines trust, talent, and long-term viability. The discussion frames sustainability as future-proofing: reducing risk exposure while improving efficiency and credibility across global supply chains. Aurigene's voice underscores the shift from compliance to competitive differentiation—b...
Read More-
Aurigene Highlights PROTAC-Driven RIPK2 Degrader Discovery at DDC 2025
2025
Dr. Gayathri Ramaswamy, Global Head of Discovery Services at Aurigene Pharmaceutical Services, presented Aurigene’s rapid design and synthesis of RIPK2 degraders at Drug Discovery Chemistry (DDC) 2025. The session showcased the company’s proprietary partial PROTAC library, rational degrader design strategies, and integrated discovery capabilities that acceler...
Read More -
From Cell Line to Clinic: A Faster Bispecific Pathway
2025
Aurigene showcased accelerated bispecific antibody execution enabled by a state-of-the-art biologics facility and high-performance upstream/downstream strategies, including N-1 perfusion for high-density cell cultures plus optimised filtration and purification. The milestone, IND clearance through patient dosing in a year, signals a partner-ready pathway for next...
Read More -
Aurigene Introduces CHEESE Database to Accelerate Hit Identification
2025
Aurigene Pharmaceutical Services has launched the Aurigene Virtual Library on the CHEESE (Chemical Exploration Engine for Similarity & Substructure Exploration) platform. The database streamlines hit identification and strengthens early discovery workflows, empowering researchers with seamless access to high-quality chemical space while reducing reliance on e...
Read More
DCAT WEEK 2026
Lotte New York Palace 455 Madison Avenue, 50th Street, New York - 10022
23-26 March, 2026
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market